UK Markets closed

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
51.20+0.25 (+0.49%)
As of 11:34AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts11111212
Avg. Estimate-1.08-1.14-4.31-4.84
Low estimate-1.28-1.33-4.87-6.01
High estimate-0.85-0.8-3.3-3.68
Year ago EPS-1.23-0.42-5.77-4.31
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts991213
Avg. Estimate8.39M6.15M36.1M31.15M
Low estimate10kN/A8.45MN/A
High estimate25M20M65.58M85M
Year ago salesN/AN/A51.84M36.1M
Sales growth (year/est)N/AN/A-30.40%-13.70%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.65-0.74-1.03-1.32
Actual EPS-1.23-0.42-0.95-1.01
Difference-0.580.320.080.31
Surprise %-89.20%43.20%7.80%23.50%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-1.08-1.14-4.31-4.84
7 days ago-1.08-1.14-4.31-4.84
30 days ago-1.08-1.14-4.31-4.84
60 days ago-1.08-1.14-4.33-4.86
90 days ago-1.09-1.16-4.61-4.94
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBEAMIndustrySector(s)S&P 500
Current qtr.12.20%N/AN/AN/A
Next qtr.-171.40%N/AN/AN/A
Current year25.30%N/AN/AN/A
Next year-12.30%N/AN/AN/A
Next 5 years (per annum)4.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A